India
Teva moves to buy Mylan
April 21, 2015Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger
Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …
Daiichi Sankyo to sell Sun Pharma stake
April 21, 2015Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, India, Ranbaxy, Sun Pharma, generics
Daiichi Sankyo is to sell off all or part of its stake in Sun Pharma and back away from the …
Sun Pharma completes Ranbaxy acquisition
March 26, 2015Manufacturing and Production, Sales and Marketing Daiichi Sankyo, India, Ranbaxy, Sun Pharma, cci
Sun Pharma has closed its mega merger deal with Ranbaxy and begun the integration of the two businesses. The combined …
Mylan buys into women’s health
February 3, 2015Sales and Marketing Abbott, FDA, India, Mylan, famy care, female, women
Mylan is to acquire a number of women’s healthcare companies from Indian-based Famy Care that will build upon its 2008 …
Sun Pharma and Ranbaxy merger gets US nod
February 2, 2015Manufacturing and Production, Sales and Marketing India, Ranbaxy, Sun Pharma, US, generics, merger, recall, torrent
The US Federal Trade Commission has given its approval for Sun Pharma’s $4 billion acquisition of troubled Indian firm Ranbaxy …
Humira biosimilar released in India
December 18, 2014Research and Development, Sales and Marketing Humira, India, Zydus Cadila, anti-inflammatory, arthritis, bioscience
Indian firm Zydus Cadila has launched the first biosimilar of AbbVie’s anti-inflammatory medicine Humira, the world’s biggest-selling drug. Used as …
Ranbaxy launches J&J biosimilar in India
December 5, 2014Manufacturing and Production, Sales and Marketing CHMP, FDA, India, J&J, JJ, Ranbaxy, Remicade, nlem, nppa
Ranbaxy has launched the first biosimilar of Johnson & Johnson’s Remicade (infliximab) in India, marking the firm’s entry into monoclonal …
India ‘likely’ to increase price caps
June 25, 2014Manufacturing and Production, Sales and Marketing China, FDA, India, UK, pricing
India’s government is ‘likely’ to increase the number of drugs which are subject to price caps, according to a report …
Dr Reddy’s recalls blood pressure drug
June 20, 2014Manufacturing and Production Dr Reddy's, India, blood pressure, metoprolol succinate, recall, toprol
Indian generics manufacturer Dr Reddy’s Laboratories is in the midst of recalling more than 13,000 bottles of blood pressure medicine …
Novartis agrees Gleevec patent deal
May 19, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Gleevec, India, Novartis, Sun Pharma, patent
Novartis has settled patent litigation with Sun Pharmaceutical Industries in the US, paving the way for the Indian company’s subsidiary …
Regulatory woes eclipse Sun Pharma deal
April 10, 2014Manufacturing and Production, Sales and Marketing FDA, India, Ranbaxy, Sun Pharma
The $4 billion merger between Indian generic firms Sun Pharma and Ranbaxy has been soured by reports that the deal …
GSK increases India stake
March 11, 2014Manufacturing and Production, Sales and Marketing FDA, GSK, India, Nashik, OTC, Thane, bangalore
GlaxoSmithKline has taken a further step into the Indian pharma market by increasing its stake in its subsidiary company there, …
FDA: India needs more inspectors
February 25, 2014Manufacturing and Production FDA, India, generics, hamburg
The Food and Drug Administration is to put more inspectors on the ground in India, following a visit there by …
India court grants Herceptin injunction
February 10, 2014Research and Development, Sales and Marketing Biocon, Herceptin, India, Mylan, Roche
Roche has been granted an injunction by a court in India to prevent generic manufacturers of its ageing breast cancer …
Gilead to allow cheaper generics of new hep C drug
February 6, 2014Manufacturing and Production, Sales and Marketing Gilead, India, generics, hep C, s&m, sofosbuvir, sovaldi
Gilead has announced the unusual step of allowing its new and highly expensive hepatitis C pill to be sold as …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
